Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suyu Shu

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Surgical Oncology|April 12, 2011
Immune response to cancer and its regulation in regional lymph nodesRongxiu Zheng, Suyu Shu
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 13, 2001
Tumor-Dendritic Cell Fusion Technology and Immunotherapy StrategiesSuyu Shu, Peter Cohen
Methods in Molecular Medicine|November 1, 2002
Adoptive immunotherapyJulian A Kim, Suyu Shu
Cellular Immunology|December 31, 2003
Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccineJorgen Kjaergaard, Keiji Shimizu, Suyu Shu
Archivum Immunologiae Et Therapiae Experimentalis|September 6, 2003
Considerations on clinical use of T cell immunotherapy for cancerGregory E Plautz, Peter A Cohen, Suyu Shu
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2002
Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodesHiroshi Tanaka, Junta Tanaka, Jørgen Kjaergaard, et al.
Cancer Research|October 19, 2005
Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cellsLi-Xin Wang, Suyu Shu, Gregory E Plautz
Cellular Immunology|April 30, 2003
Therapeutic immune response induced by electrofusion of dendritic and tumor cellsHiroshi Tanaka, Keiji Shimizu, Takashi Hayashi, et al.
Clinical Immunology (Orlando, Fla.)|July 17, 2003
Therapeutic efficacy of adoptive immunotherapy is predicated on in vivo antigen-specific proliferation of donor T cellsJørgen Kjaergaard, Liaomin Peng, Peter A Cohen, et al.
Critical Reviews in Immunology|January 17, 2008
Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapySuyu Shu, Rongxiu Zheng, Walter T Lee, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Surgical Oncology|April 12, 2011
Immune response to cancer and its regulation in regional lymph nodesRongxiu Zheng, Suyu Shu
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 13, 2001
Tumor-Dendritic Cell Fusion Technology and Immunotherapy StrategiesSuyu Shu, Peter Cohen
Methods in Molecular Medicine|November 1, 2002
Adoptive immunotherapyJulian A Kim, Suyu Shu
Cellular Immunology|December 31, 2003
Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccineJorgen Kjaergaard, Keiji Shimizu, Suyu Shu
Archivum Immunologiae Et Therapiae Experimentalis|September 6, 2003
Considerations on clinical use of T cell immunotherapy for cancerGregory E Plautz, Peter A Cohen, Suyu Shu
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2002
Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodesHiroshi Tanaka, Junta Tanaka, Jørgen Kjaergaard, et al.
Cancer Research|October 19, 2005
Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cellsLi-Xin Wang, Suyu Shu, Gregory E Plautz
Cellular Immunology|April 30, 2003
Therapeutic immune response induced by electrofusion of dendritic and tumor cellsHiroshi Tanaka, Keiji Shimizu, Takashi Hayashi, et al.
Clinical Immunology (Orlando, Fla.)|July 17, 2003
Therapeutic efficacy of adoptive immunotherapy is predicated on in vivo antigen-specific proliferation of donor T cellsJørgen Kjaergaard, Liaomin Peng, Peter A Cohen, et al.
Critical Reviews in Immunology|January 17, 2008
Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapySuyu Shu, Rongxiu Zheng, Walter T Lee, et al.
Pageof 4